SEC FORM 3

Please wait

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Banerjee Anindya

(Last)

(First)

(Middle)

ICICI BANK TOWERS

BANDRA-KURLA COMPLEX

(Street)

MUMBAI

400051

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ICICI BANK LTD [ IBN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Group Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Equity Shares, par value Rs. 2 per share	450,038	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽¹⁾	⁽¹⁾	Equity Shares, par value Rs. 2 per share	96,600⁽²⁾	$14.67⁽³⁾	D
Stock Option (Right to Buy)	⁽⁴⁾	⁽⁴⁾	Equity Shares, par value Rs. 2 per share	101,800⁽²⁾	$12.04⁽³⁾	D
Stock Option (Right to Buy)	⁽⁵⁾	⁽⁵⁾	Equity Shares, par value Rs. 2 per share	101,200⁽²⁾	$9.67⁽³⁾	D
Stock Option (Right to Buy)	⁽⁶⁾	⁽⁶⁾	Equity Shares, par value Rs. 2 per share	89,200⁽²⁾	$8.09⁽³⁾	D
Stock Option (Right to Buy)	⁽⁷⁾	⁽⁷⁾	Equity Shares, par value Rs. 2 per share	90,600⁽²⁾	$6.16⁽³⁾	D
Stock Option (Right to Buy)	⁽⁸⁾	⁽⁸⁾	Equity Shares, par value Rs. 2 per share	98,350⁽²⁾	$3.65⁽³⁾	D
Stock Option (Right to Buy)	⁽⁹⁾	⁽⁹⁾	Equity Shares, par value Rs. 2 per share	56,840⁽²⁾	$4.35⁽³⁾	D
Stock Option (Right to Buy)	⁽¹⁰⁾	⁽¹⁰⁾	Equity Shares, par value Rs. 2 per share	214,225⁽²⁾	$2.71⁽³⁾	D
Stock Option (Right to Buy)	⁽¹¹⁾	⁽¹¹⁾	Equity Shares, par value Rs. 2 per share	106,067⁽²⁾	$2.4⁽³⁾	D
Stock Option (Right to Buy)	⁽¹²⁾	⁽¹²⁾	Equity Shares, par value Rs. 2 per share	239,250⁽²⁾	$2.64⁽³⁾	D
Stock Option (Right to Buy)	⁽¹³⁾	⁽¹³⁾	Equity Shares, par value Rs. 2 per share	63,800⁽²⁾	$3.03⁽³⁾	D

Explanation of Responses:

1. A total of 96,600 stock options granted on April 17, 2025 and vesting in three tranches: (i) 28,980 vesting on April 17, 2026 and expiring on April 16, 2031, (ii) 28,980 vesting on April 17, 2027 and expiring on April 16, 2032, and (iii) 38,640 vesting on April 17, 2028 and expiring on April 16, 2033.

2. Each stock option represents the contingent right to apply for one Equity Share.

3. The exercise prices of the stock options are denominated in Rupee and translated for convenience only into USD at the rate of INR92.47 to US$1.00, the exchange rate set forth int he H.10 statistical release of the Federal Reserve Board on March 13, 2026.

4. A total of 101,800 stock options granted on April 26, 2024 and vesting in three tranches: (i) 30,540 vested on April 26, 2025 and expiring on April 25, 2030, (ii) 30,540 vesting on April 26, 2026 and expiring on April 25, 2031, and (iii) 40,720 vesting on April 26, 2027 and expiring on April 25, 2032.

5. A total of 101,200 stock options granted on April 21, 2023 and vesting in three tranches: (i) 30,360 vested on April 21, 2024 and expiring on April 20, 2029, (ii) 30,360 vested on April 21, 2025 and expiring on April 20, 2030, and (iii) 40,480 vesting on April 21, 2026 and expiring on April 20, 2031.

6. A total of 89,200 stock options granted on April 23, 2022 and vesting in three tranches: (i) 26,760 vested on April 23, 2023 and expiring on April 22, 2028, (ii) 26,760 vested on April 23, 2024 and expiring on April 22, 2029, and (iii) 35,680 vested on April 23, 2025 and expiring on April 22, 2030.

7. A total of 90,600 stock options granted on April 24, 2021 and vesting in three tranches: (i) 27,180 vested on April 24, 2022 and expiring on April 23, 2027, (ii) 27,180 vested on April 24, 2023 and expiring on April 23, 2028, and (iii) 36,240 vested on April 24, 2024 and expiring on April 23, 2029.

8. A total of 140,500 stock options granted on May 9, 2020 and vesting in three tranches: (i) 42,150 vested on May 9, 2021 and expiring on May 8, 2026, which have been fully exercised by the Reporting Person prior to expiration, (ii) 42,150 vested on May 9, 2022 and expiring on May 8, 2027, and (iii) 56,200 vested on May 9, 2023 and expiring on May 8, 2028.

9. A total of 142,100 stock options granted on May 6, 2019 and vesting in three tranches: (i) 42,630 vested on May 6, 2020 and expired on May 5, 2025, which have been fully exercised by the Reporting Person prior to expiration, (ii) 42,630 vested on May 6, 2021 and expiring on May 5, 2026, which have been fully exercised by the Reporting Person prior to expiration, and (iii) 56,840 vested on May 6, 2022 and expiring on May 5, 2027.

10. A total of 214,225 stock options granted on May 3, 2017 and vesting in three tranches: (i) 64,268 vested on May 3, 2018 and expiring on May 2, 2028, (ii) 64,267 vested on May 3, 2019 and expiring on May 2, 2029, and (iii) 85,690 vested on May 3, 2020 and expiring on May 2, 2030.

11. A total of 151,525 stock options granted on April 28, 2016 and vesting in three tranches: (i) 45,458 vested on April 28, 2017 and expiring on April 27, 2027, which have been fully exercised by the Reporting Person prior to expiration, (ii) 45,457 vested on April 28, 2018 and expiring on April 27, 2028, and (iii) 60,610 vested on April 28, 2019 and expiring on April 27, 2029.

12. A total of 239,250 stock options granted on September 16, 2015 and vesting in two tranches: (i) 119,625 vested on April 30, 2018 and expiring on April 29, 2028 and (ii) 119,625 vested on April 30, 2019 and expiring on April 29, 2029.

13. A total of 159,500 stock options granted on April 27, 2015 and vesting in three tranches: (i) 47,850 vested on April 27, 2016 and expiring on April 26, 2026, which have been fully exercised by the Reporting Person prior to expiration, (ii) 47,850 vested on April 27, 2017 and expiring on April 26, 2027, which have been fully exercised by the Reporting Person prior to expiration, and (iii) 63,800 vested on April 27, 2018 and expiring on April 26, 2028.

Remarks:

Exhibit 24.1. See power of attorney attached

	/s/ Vivek Ranjan, as Attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.